CALGARY, Alberta, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSXV: VITA) (OTCQB: VTLSF) ("Vitalist", "we", "our", or the "Company"), a dynamic global smartwatch company known for its strategic partnerships with global brands, today announced its financial results for the nine months ended December 31, 2025 ("Q3 2026"). The related financial statements and accompanying notes, and Management's Discussion and Analysis for Q3 2026 ("MD&A") are available on SEDAR+ at www.sedarplus.ca and on the Vitalist's website at www.vitalist.co.
All dollar amounts in this press release are expressed in Canadian dollars.
Q3 2026 Highlights
-- Consistent Nine-Month Revenue: Revenue for the nine-month period ended
December 31, 2025, was $4.08 million, representing a nominal increase
compared to $4.06 million in the prior year.
-- Reebok Sales Momentum: The Reebok Smartwatches, launched in August 2025,
carried a higher average selling price and were sold in slightly lower
volumes than the legacy Motorola products. The increase in gross sales
was offset by higher estimated selling costs for the Reebok products.
-- Expansion of Margins: Gross profit margin for the three-month period
ended December 31, 2025, increased slightly to 45% (compared to 44% in
the prior year) due to the higher-margin Reebok product line, partially
offset by higher estimated selling costs.
-- Net Loss Drivers: The Company recorded a net loss of $2.20 million for
the quarter and $2.51 million for the nine months ended December 31,
2025. This was primarily driven by a $0.64 million write-off of the
prepaid minimum guaranteed royalty, increased sales and marketing
expenses, as well as unfavourable swings in foreign exchange.
-- Operating Cash Flow: Cash used in operating activities was $1.61 million
for the nine-month period, compared to $1.09 million in the prior year,
the increase was largely due to the prepayment of Reebok licensing fees
in the current period.
-- U.S. Market Expansion: On October 9, 2025, Vitalist expanded its presence
by listing on the OTCQB Venture Market under the symbol VTLSF.
Outlook
Building on the successful launch of the Reebok Pulse and Icon smartwatches, Vitalist has started to sell the Rush and Stride smartwatch products and is preparing for the release of its proprietary VitalOS$(TM)$ platform on the Reebok Kinetic. The VitalOS platform is expected to revolutionize health and wellness experiences by providing broad hardware compatibility and a highly customizable software experience. The flagship VitalOS(TM)-powered products are anticipated in the first half of calendar 2026, further supporting the Company's growth and integration of biometric data insights.
The Company has also partnered with Pattern Inc., the global standard for ecommerce acceleration, to expand its digital reach and help drive higher sales volumes.
Selected Financial Information
Three months ended Nine months ended
December 31 December 31
2025 2024 2025 2024
$ $ $ $
------------ ----------- ---------- ----------- -----------
Total
revenue 659,535 1,239,610 4,077,347 4,064,164
Gross profit 294,789 542,435 1,531,541 1,550,504
Net loss (2,196,712) (743,246) (2,509,044) (2,097,476)
Net cash
provided by
(used in)
operating
activities 833,171 (858,396) (1,610,968) (1,086,226)
------------ ---------- --------- ---------- ----------
Basic &
Diluted
loss per
share (0.04) (0.02) (0.05) (0.05)
------------ ---------- --------- ---------- ----------
March 31,
December 2025
As at 31, 2025 $ $
Total assets 1,355,957 1,127,789
Total
non-current
financial
liabilities 6,439,647 -
------------ ---------- --------- ---------- ----------
About Vitalist Inc.
Vitalist Inc. is an innovative technology provider that helps brands build better products. Through VitalOS(TM), brands create seamlessly connected devices and applications that adapt to each user. By uniting hardware and software with intelligent analytics, we're building an ecosystem of personalized solutions that enhance human potential.
For more information visit: www.vitalist.co | Investor Materials
Join the Vitalist distribution list: www.vitalist.co/investors
Investor Relations Contact
For further information about Vitalist Inc. please contact:
Kalvie Legat, CEO
Vitalist
+1 (403) 560-9635
ir@vitalist.ca
Walter Frank
IMS Investor Relations
+1 (203) 972-9200
vitalist@imsinvestorrelations.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian securities laws. In general, forward-looking information is disclosure about future conditions, courses of action, and events, including information about prospective financial performance or financial position. The use of any of the words "anticipates", "believes", "expects", "intends", "plans", "will", "would", and similar expressions are intended to identify forward-looking information. Forward-looking statements included or incorporated by reference in this press release include, without limitation, with respect to:
-- the ability of the Company to continue as a going concern;
-- the impact on the Company of the voluntary assignment into bankruptcy of
eBuyNow eCommerce Ltd. ("EBN"), a wholly-owned Canadian subsidiary of the
Company, which was filed by EBN on June 27, 2023 pursuant to
the Bankruptcy and Insolvency Act (R.S.C., 1985, c. B-3) (the "Act")
(collectively, the "Bankruptcy");
-- the effects of global supply constraints on the Company and the
likelihood that such constraints will continue to occur and impact the
Company;
-- the plans of the Company for the Reebok (defined below) product category,
the status of the Reebok product category relative to those plans, and
the anticipated timing and costs to advance the Reebok product category;
-- the plans of the Company for the Vitalist (defined below) product
category, the status of the Vitalist product category relative to those
plans, and the anticipated timing and costs to advance the Vitalist
product category;
-- the plans of the Company to terminate certain product lines and product
categories;
-- the strategies of the Company for customer retention and growth;
-- anticipated demand for the products and services of the Company, and its
ability to meet that demand;
-- the Company's intent to maintain a flexible capital structure;
-- the ability of the Company to generate sufficient cash to maintain its
capacity and fund its growth and development;
-- fluctuations in the liquidity of the Company;
-- the ability of the Company to meet its obligations as they become due;
-- the plans of the Company for remedying its working capital deficiency;
-- the need for the Company to pursue additional sources of financing and
the ability of the Company to obtain such additional sources of
financing;
-- capital expenditures not yet committed, but required, to maintain the
capacity of the Company and fund its growth and development;
-- fluctuations in the capital resources of the Company;
-- the sources of financing that the Company has arranged, but not yet used;
and
-- the plans of the Company to reduce general and administrative expenses.
The forward-looking information is based on certain key expectations and assumptions, including the continuance of manufacturing operations at the Company's partner factories in Asia, the timing of product launches, shipments and deliveries, forecast sales price and sales volumes of the Company's products and the ability of the Company to secure additional sources of financing in the future.
There can be no assurance that the Company will be able to secure additional financing in the future in a timely manner or at all. If the Company fails to secure additional financing, the Company may have insufficient liquidity and capital resources to operate its business resulting in material uncertainty regarding the Company's ability to meet its financial obligations as they become due and continue as a going concern.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company cannot give any assurance that it will prove to be accurate. By its nature, forward-looking information is subject to various risks, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed in this MD&A. Such risks and uncertainties include, without limitation:
-- there is the potential for litigation to arise from creditors in
connection with the Bankruptcy resulting in contingent liabilities and
additional legal costs to the Company;
-- certain liabilities of EBN and its subsidiaries may not be extinguished
in connection with the Bankruptcy;
-- the Company may require additional funds by way of debt or equity
financings to continue to fund its operating, investing, and financing
(MORE TO FOLLOW) Dow Jones Newswires
February 12, 2026 17:29 ET (22:29 GMT)